in HIV isolates from patients failing PI
For example, Abbott Laboratories has a new-generation protease inhibitor known as ABT-378
that in lab tests has shown itself to be more powerful than the protease inhibitors on the market.
The medical community is favorably impressed with Kaletra (lopinavir, formerly ABT-378
, the newly-approved "second generation" protease inhibitor.
Researchers reported on several new drugs--such as ABT-378
from Abbott Laboratories and T-20 from Trimeris Inc.